mesalamine has been researched along with Depressive Disorder in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Selinger, CP | 1 |
| Eaden, J | 1 |
| Jones, DB | 1 |
| Katelaris, P | 1 |
| Chapman, G | 1 |
| McDonald, C | 1 |
| Smith, P | 1 |
| Lal, S | 1 |
| Leong, RW | 1 |
| McLaughlin, J | 1 |
| Robinson, A | 1 |
1 other study available for mesalamine and Depressive Disorder
| Article | Year |
|---|---|
Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease.
Topics: Anxiety Disorders; Biological Factors; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Depressiv | 2013 |